IMMUNE DYSREGULATION IN PATIENTS WITH MYALGIC ENCEPHALOMYELITIS/ CHRONIC FATIGUE SYNDROME


如何引用文章

全文:

作者简介

N Didkovsky

FSBIS FSCC of physical-chemical medicine

D Ogurtsov

FSBIS FSCC of physical-chemical medicine

S Krynskiy

FSBIS FSCC of physical-chemical medicine; National Research Center “Kurchatov Institute”

O Gurskaya

FSBIS FSCC of physical-chemical medicine

I Kompaneets

FSBIS FSCC of physical-chemical medicine

N Hailov

National Research Center “Kurchatov Institute”

I Malashenkova

FSBIS FSCC of physical-chemical medicine; National Research Center “Kurchatov Institute”

参考

  1. Carruthers B.M., M. I. van de Sande, K. L. De Meirleir, et al. Myalgic encephalomyelitis: International Consensus Criteria. 2011, Volume 270, Issue 4, pages 327-338.
  2. Малашенкова И.К., Дидковский Н.А., Говорун В.М. и соавт. Роль вируса Эпштейна-Барр в развитии синдрома хронической усталости и иммунной дисфункции. International Journal of Immunorehabilitation. 2000, 2(1): 102-110.
  3. Kondo K. Chronic fatigue syndrome and herpesvirus reactivation. Nihon Rinsho. 2007; 65(6): 1043-8.
  4. Robertson E, editor. Epstein-Barr virus.1st edition Vol. 1.Caister Academic Press; Norfolk, England: 2005.
  5. Schmiedel D., Tai J., Levi-Schaffer F., et al.Human Herpesvirus 6B Downregulates Expression of Activating Ligands during Lytic Infection To Escape Elimination by Natural Killer Cells. J Virol. 2016 Oct 14;90(21):9608-9617.
  6. Xiao N, Chen Q, Cai S.Regulation and evasion of host immune responses by Epstein-Barr virus.Wei Sheng Wu XueBao. 2016 Jan 4;56(1):19-25.
  7. Albanese M., Tagawa T., Bouvet M., et al.Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.Proc Natl AcadSci U S A. 2016 Oct 18;113(42):E6467-E6475.
  8. Tsai Sy, Yang TY, Chen HJ, et al. Increased risk of chronic fatigue syndrome following herpes zoster: a population-based study.Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1653-9.
  9. Lerner AM,BeqajSH, Deeter Rg, Fitzgerald JT. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with chronic fatigue syndrome. In Vivo 2004; 18:101-106.
  10. Bansal AS, Bradley AS, Bishop KN, et al. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun. 2012 Jan;26(1):24-31.
  11. Russell L., Broderick G. Taylor R., et al. Illness progression in chronic fatigue syndrome: a shifting immune baseline. BMC Immunol. 2016 Mar 10;17:3.
  12. Maes M., Bosmans E., Kubera M. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD 19+ expression and CD4+/CD8+ ratio, but no associations with (auto) immune, leaky gut, oxidative and nitrosative stress biomarkers. Neuro Endocrinol Lett. 2015;36(5):439-46.
  13. Read R., Spickett G., Harvey J., et al. IgG1 subclass deficiency in patients with chronic fatigue syndrome. Lancet. 1988, 1(8579): 241-242.

版权所有 © Pharmarus Print Media, 2017

##common.cookie##